Effect of fatty acid-binding protein 2 Ala54Thr genotype on weight loss and cardiovascular risk factors after a high-polyunsaturated fat diet in obese patients

Journal of Investigative Medicine

Volumn 60, Issue 8, 2012, Pages 1194-1198

  De Luis, Daniel ^a   Aller, Rocio ^a   Izaola, Olatz ^a   Sagrado, Manuel Gonzalez ^a   De La Fuente, Beatriz ^a   Conde, Rosa ^a   Primo, David ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Ala54Thr FABP2; Diet; Obesity; Polyunsaturated fat

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID BINDING PROTEIN 2; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; RESISTIN; SATURATED FATTY ACID; TRIACYLGLYCEROL; ALANINE; CARBOHYDRATE; GENOMIC DNA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROTEIN; THREONINE;

ADULT; ALLELE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FABP2 GENE; FAT INTAKE; FEMALE; GENE; GENOTYPE; HETEROZYGOTE; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; WEIGHT REDUCTION; DNA POLYMORPHISM; FAT MASS; HOMEOSTASIS MODEL ASSESSMENT; INSULIN BLOOD LEVEL; LIPID DIET; MIDDLE AGED; WAIST CIRCUMFERENCE;

ADULT; ALANINE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DIETARY FATS, UNSATURATED; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; THREONINE; WEIGHT LOSS;

EID: 84873627090     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e318271fb25     Document Type: Article

References (30)

1. Alerts TC. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
2. Elmadfa I, Freisling H. Fat intake, diet variety and health promotion. Forum Nutr. 2005;57:1-10.
3. Jiang R, Manson JAE, Stampfer MJ, et al. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288:2554-2560.
4. Storlien LH, Tapsell LC, Calvert GD. Role of dietary factors: macronutrients. Nutr Rev. 2000;58:S7-S9.
5. Storlien LH, Baur LA, Kriketos AD, et al. Dietary fats and insulin action. Diabetologia. 1996;39:621-631.
6. de Luis DA, Aller R, Izaola O, et al. Influence of Ala54thr polymorphism of the fatty acid-binding protein 2 gene on obesity and cardiovascular risk factors. Horm Metab Res. 2007;39:830-834.
7. De Luis DA, Gonzalez Sagrado M, Aller R, et al. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2. Eur Rev Med Pharmacol Sci. 2010;14:89-95.
8. Aller R, de Luis DA, Fernadez L, et al. Influence of Ala 54thr polymorphism of fatty acid binding proteín 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. Eur Rev Med Pharmacol Sci. 2009;13:157-162.
9. Meier U, Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511-1525.
10. de Luis DA, Aller R, Izaola O, et al. Modulation of the response to a lifestyle modification in obese patients by ala54thr polymorphism of the fatty acid-binding protein 2 gene. Ann Nutr Metab. 2006;50:354-360.
11. Weiss E, Brandauer J, Kulaputana O, et al. FABP2 Ala 54Thr genotype is associated with glucoregulatory function and lipid oxidation after a high-fat meal in sedentary nondiabetic men and women. Am J Clin Nutr. 2007;85:102-108.
12. Matsuzawa Y. Adipocytokines: emerging therapeutic targets. Curr Atheroscler Rep. 2005;7:58-62.
13. Mathews DR, Hosker JP, Rudenski AS, et al. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-414.
14. Duart MJ, Arroyo CO, Moreno JL. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med. 2002;40:1161-1167.
15. Pfutzner A, Langefeld M, Kunt T, et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab. 2003;49:571-576.
16. Suominen P. evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem. 2004;50:219-221.
17. Lukaski H, Johson PE. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41(4):810-817.
18. Mataix J, Mañas M. Tablas de Composición de Alimentos Españoles. Granada, Spain: University of Granada; 2003.
19. Storch J, Veerkamp JH, Hsu KT. Similar mechanisms of fatty acid transfer from human and rodent fatty acid binding proteins to membranes: liver, intestine, heart muscle, and adipose tissue FABPS. Mol Cell Biochem. 2002;239:25-33.
20. Levy E, Menard D, Delvin E. The polymorphism at codón 54 of the FAbP2 gene increases fat absorption in human intestinal explants. J Biol Chem. 2001;276:29679-29684.
21. Baier LJ, Bogardus C, Sacchettini JC. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem. 1996;271:10892-10896.
22. Sipilainen R, Uusitupa M, Heikkinen S, et al. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab. 1997;82:2629-2632.
23. Baier LJ, Sacchettini JC, Knowler WC. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest. 1995;95:1281-1287.
24. Dworatzek P, Hegele R, Wolever T. Postprandial lipemia in subjects with threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr. 2004;79:1110-1117.
25. Marin C, Perez Jimenez F, Gomez P, et al. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr. 2005;82:196-200.
26. Hegele RA, Wolever TM, Store JA, et al. Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest. 1997;27:857-862.
27. Frayn KN, Karpe F, Fielding BA, et al. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord. 2003;27:875-888.
28. Monzillo LU, Hamdy O, Horton ES, et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obesity Research. 2003;11:1048-1052.
29. Carlsson M, Orho Melander M, Hedenbro J, et al. The T54 allele of the intestinal fatty acid-binding protein 2 is associated with parenteral history of stroke. J Clin Endocrinol Metab. 2000;85:2801-2804.
30. Georgopoulos A, Aras O, Noutsou M, et al. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab. 2002;87:3735-3739.